Northvale company reports first quarter results

August 30, 2018 by  

ADM Tronics Unlimited, Inc. (ADMT), a Northvale-based technology company, recently released its results for the first fiscal quarter of Fiscal Year 2019, which ended June 30, 2018, showing a profit.

The company previously said it would be redefining its strategy for business growth by following its strategic plan. The plan calls for the company to redirect more financial resources to engineering, researching, developing, and producing its own products. ADMT has developed proprietary medical technologies that include Sonotron®, a device that uses a mild electrical charge to treat pain; Aurex-3®, a technological device that treats and controls tinnitus; and Alvio ®, a device that helps treat COPD, asthma, and other respiratory difficulties. As ADM takes these devices through various developmental stages, revenues from device manufacturing and engineering services lessened, although a quarterly profit was posted.

Andre’ DiMino, ADMT’s president, said the company planned to continue using more of its developmental and engineering resources to improve their own medical technologies, believing that investing in its own products is the best way to insure the company’s future growth. Companies such as this, which manufacture complex products, can use brochure printing to create informational and instruction manuals for purchasers.

ADMT has the ability to envision a technology, develop it, and manufacture and bring it to market, all in-house. ADMT concentrates in three areas: proprietary electronic devices for medical uses; manufacturing, engineering, and other services; and creating safe, eco-friendly formulations using waster as a base.